Certified by Founder Lodge
Gilgamesh Ventures
United States - New York, New York
INVESTOR
1 Disclosed Funding Rounds $3,500,000
15 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Gilgamesh Ventures is a seed-stage investment fund focused on fintech in the Americas.
| Company | Date | Round | Raised |
|---|---|---|---|
 Nexu |
January, 25 ,2022 | Series A | $50,000,000 |
 Poolit |
December, 16 ,2022 | Seed | $5,300,000 |
 Palenca |
January, 19 ,2022 | Series A | $2,600,000 |
 Xepelin |
May, 05 ,2022 | Series B | $111,000,000 |
 Mundi |
February, 15 ,2022 | Series A | $16,000,000 |
 Boom |
June, 06 ,2023 | Seed | $4,500,000 |
| Nexu |
January, 25 ,2022 | Series A | $50,000,000 |
 Preczn Inc |
October, 25 ,2023 | Unknown | $6,800,000 |
| Palenca |
January, 19 ,2022 | Series A | $2,600,000 |
 Baselayer |
May, 02 ,2024 | Seed | $6,500,000 |
| Boom |
June, 06 ,2023 | Seed | $4,500,000 |
 Niva |
July, 09 ,2024 | Unknown | $3,300,000 |
| Preczn Inc |
October, 25 ,2023 | Unknown | $6,800,000 |
| Baselayer |
May, 02 ,2024 | Seed | $6,500,000 |
| Niva |
July, 09 ,2024 | Unknown | $3,300,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
